Pharmaceutical development is really just throwing mud at a wall and seeing what sticks. Sometimes, something sticks and you get rich, sometimes it doesn't and

Pharmaceutical development is really just throwing mud at a wall and seeing what sticks. Sometimes, something sticks and you get rich, sometimes it doesn't and you get nothing. If during one of those failed attempts you came across something useful but not lucrative, I think the cost of bringing it to market should start at that point, and should not include all the trials when you were looking for the cash cow that you had to do anyway. shrug